48,860
edits
Difference between revisions of "Vasculitides"
Jump to navigation
Jump to search
m
→Overview: subdivide
m (→Overview: subdivide) |
|||
| Line 2: | Line 2: | ||
==Overview== | ==Overview== | ||
Most common | ===Most common<ref>TN05 RH3.</ref>=== | ||
*Polyarteritis nodosa (PAN). | *Polyarteritis nodosa (PAN). | ||
*Microscopic polyangiitis. | *Microscopic polyangiitis. | ||
| Line 10: | Line 10: | ||
===Grouping by size=== | ===Grouping by size=== | ||
Small vessel vasculitides | ====Small vessel vasculitides==== | ||
*Predominantly cutaneous vasculitis. | *Predominantly cutaneous vasculitis. | ||
*Henoch-Schoenlein purpura. | *Henoch-Schoenlein purpura. | ||
| Line 18: | Line 18: | ||
**Churg-Strauss syndrome (50% ANCA +ve). | **Churg-Strauss syndrome (50% ANCA +ve). | ||
**Microscopic polyangiitis (usually p-ANCA). | **Microscopic polyangiitis (usually p-ANCA). | ||
Notes: | Notes: | ||
*ANCA = anti-neutrophil cytoplasmic antibodies. | *ANCA = anti-neutrophil cytoplasmic antibodies. | ||
====Large vessel vasculitides<ref>TN05 RH20.</ref>==== | |||
*Giant cell arteritis (AKA ''temporal arteritis''). | |||
*Takayasu's arteritis. | |||
==Giant cell arteritis== | ==Giant cell arteritis== | ||